Literature DB >> 14644871

High incidence of hepatotoxicity of isoniazid treatment for tuberculosis chemoprophylaxis in patients with rheumatoid arthritis treated with methotrexate or sulfasalazine and anti-tumour necrosis factor inhibitors.

J Vanhoof, S Landewe, E Van Wijngaerden, P Geusens.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14644871      PMCID： PMC1754392          DOI： 10.1136/ard.2002.004598

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  15 in total

1.  Does isoniazid chemoprophylaxis increase the frequency of hepatotoxicity in patients receiving anti-TNF-α agent with a disease-modifying antirheumatic drug?

Authors:  Döndü Üsküdar Cansu; Sabri Güncan; N Şule Yaşar Bilge; Timuçin Kaşifoğlu; Cengiz Korkmaz
Journal:  Eur J Rheumatol       Date:  2014-06-01

2.  High incidence of intolerance to tuberculosis chemoprophylaxis.

Authors:  Muhammad Haroon; Una Martin; Joe Devlin
Journal:  Rheumatol Int       Date:  2010-07-24       Impact factor: 2.631

3.  Isoniazid intervention for latent tuberculosis among 86 patients with rheumatologic disease administered with anti-TNFalpha.

Authors:  Ismail Hanta; Suleyman Ozbek; Sedat Kuleci; Murat Sert; Ali Kocabas
Journal:  Clin Rheumatol       Date:  2007-02-27       Impact factor: 2.980

4.  Increased incidence of liver enzymes abnormalities in patients treated with isoniazid in combination with disease modifying and/or biologic agents.

Authors:  Josiane Bourré-Tessier; Mireia Arino-Torregrosa; Denis Choquette
Journal:  Clin Rheumatol       Date:  2014-02-21       Impact factor: 2.980

5.  Comparison of in vitro-specific blood tests with tuberculin skin test for diagnosis of latent tuberculosis before anti-TNF therapy.

Authors:  Jérémie Sellam; Haifa Hamdi; Carine Roy; Gabriel Baron; Marc Lemann; Xavier Puéchal; Maxime Breban; Francis Berenbaum; Marc Humbert; Karin Weldingh; Dominique Salmon; Philippe Ravaud; Dominique Emilie; Xavier Mariette
Journal:  Ann Rheum Dis       Date:  2007-04-24       Impact factor: 19.103

6.  A case of Poncet disease diagnosed with interferon-gamma-release assays.

Authors:  Heikki Valleala; Tamara Tuuminen; Heikki Repo; Kari K Eklund; Marjatta Leirisalo-Repo
Journal:  Nat Rev Rheumatol       Date:  2009-11       Impact factor: 20.543

7.  Repeated tuberculin skin testing following therapy with TNF-alpha inhibitors.

Authors:  Inbal Fuchs; Lone Avnon; Tamar Freud; Mahmoud Abu-Shakra
Journal:  Clin Rheumatol       Date:  2008-09-16       Impact factor: 2.980

8.  Choice of Biologic Therapy for Patients with Rheumatoid Arthritis: The Infection Perspective.

Authors:  Filip De Keyser
Journal:  Curr Rheumatol Rev       Date:  2011-02

9.  Acute and Fatal Isoniazid-Induced Hepatotoxicity: A Case Report and Review of the Literature.

Authors:  Wissam K Kabbara; Aline T Sarkis; Paola G Saroufim
Journal:  Case Rep Infect Dis       Date:  2016-08-25

10.  Screening for latent tuberculosis before starting TNF-alpha inhibitors in a population with high BCG vaccination rates.

Authors:  Aysa Hacioglu; Sermin Borekci; Melike Melikoglu; Yesim Ozguler; Sinem Nihal Esatoglu; Serdal Ugurlu; Emire Seyahi; Izzet Fresko; Vedat Hamuryudan; Huri Ozdogan; Sebahattin Yurdakul; Ibrahim Hatemi; Aykut Ferhat Celik; H Gul Ongen; Gulen Hatemi
Journal:  Rheumatol Int       Date:  2021-07-06       Impact factor: 3.580
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.